Before your Rhode Island practice orders
Start by confirming your current licensure standing with the board that governs your profession, and confirm that any medspa location has a medical director who documents supervision of biologic product use on site.
Check whether the state's pharmacy board or Department of Health has issued guidance on receiving and storing human cell and tissue products, and have your own counsel assess how 21 CFR 1271.10 applies to the specific intended use at your practice. If you are also considering an exosome product, that is a separate question for counsel: FDA has stated there are no FDA-approved exosome products, and these products are generally regulated as biologic drugs under section 351 of the Public Health Service Act.
- Licensure standing with your governing board
- Documented medical director supervision at medspa locations
- State guidance on HCT/P receiving and storage
- Counsel's review of 1271.10 and exosome biologic-drug status
Providence, by the registry
NPPES registry counts for providers located in Providence show roughly 111 orthopedic, 29 pain management, and 85 aesthetic medicine registrations. Because Rhode Island is geographically small, Providence accounts for most of the state's relevant provider base in these categories, but the figures still describe only Providence-registered providers, not a statewide total and not a measure of purchasing activity.
We recommend checking current NPPES figures directly before using them to plan outreach, since registry counts change over time.
Opening and shipping a Rhode Island account
Every account is verified against an NPI number through the NPPES registry before a first order ships. Cryopreserved products move overnight on dry ice in validated containers for -80 degree Celsius storage on arrival, while lyophilized formats ship at ambient temperature with handling instructions in the accompanying insert.
Each lot carries a unique identifier, and documentation including a certificate of analysis, donor eligibility summary, and lot release record is available on request for lot-level tracking at the patient record level. A documentation-focused peer-to-peer call can be arranged for your medical director on request.
These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.
Frequently asked questions
Is Rhode Island's smaller provider base a limitation on which products we can order?+
No. Account access depends on NPI verification, not the size of the local market, so a verified Rhode Island account can order from the full product range.
Do the Providence figures include practices outside the city?+
No. The NPPES counts cited here reflect providers registered specifically in Providence. Practices elsewhere in the state are not included in that figure, even if they are part of the same metro area informally.
What should our Providence medspa confirm before ordering an exosome product?+
Confirm that a licensed medical director documents supervision of biologic product use at the location, and have your own counsel review the exosome product's status as a biologic drug under section 351, since FDA has stated no exosome product is currently FDA-approved.